Calvin Scott Recalls Phentermine 15mg Capsules Due to Packaging Defect
Calvin Scott & Company is recalling Phentermine 15mg capsules because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a CGMP deviation regarding packaging that could compromise drug stability, fitting the criteria for moderate severity without reported injuries.
Plain-English summary
Calvin Scott & Company, Inc. is recalling Phentermine 15mg grey/Yellow Capsules, 28-count bags. The product is distributed nationwide within the United States. The specific lot affected is Lot #19330 with an expiration date of 12/20.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the light-sensitive drug products were repackaged in transparent or partially transparent pouches, which does not meet regulatory standards for protecting the medication from light.
Consumers should stop using the affected product and contact their healthcare provider or pharmacist for guidance on disposal or replacement. The product is prescription-only, so patients should consult their prescriber regarding next steps.
The recalled product
- Product
- Phentermine 15mg grey/Yellow Capsules, 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: Sunrise Pharm., Rahway NJ, 07065; NDC 11534-0157-03
- Manufacturer
- Calvin Scott & Company, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #:19330
- Exp. Date: 12/20
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 19 recalled by Calvin Scott & Company, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 19 products in this recall →Related recalls
Same manufacturer · Calvin Scott & Company, Inc.
See all →- ModerateBenzphetamine tablets recalled due to label mix-up with Benzonatate
FDA (Drugs) · 2022-06-01
- SevereBenzonatate 100mg Capsules Label Mix-up — Wrong Medication in Bottles
FDA (Drugs) · 2022-06-01
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Stability Deviations
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Missing Stability Studies
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Phentermine Capsules Due to Stability Study Deviations
FDA (Drugs) · 2020-10-14
Same hazard · packaging defect
See all →- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- HighCardinal Health Recalls Presource Convenience Kits Due to Seal Defects
FDA (Devices) · 2026-09-30
- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighCardinal Health Recalls Presource Convenience Kits Due to Potential Seal Defects
FDA (Devices) · 2026-09-30
Similar recalls
- ModerateCalvin Scott Recalls Phentermine Capsules Due to Stability Study Deviations
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Stability Deviations
FDA (Drugs) · 2020-10-14
- ModerateCardinal Health Recalls Phentermine HCL 30mg Capsules Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Phentermine HCL Capsules Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModeratePhentermine Hydrochloride Capsules 30mg Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Missing Stability Studies
FDA (Drugs) · 2020-10-14